Thermo Fisher Feb 18, 2026 Michael Hakes' Top Picks: Nu Holdings, Thermo Fisher Scientific & Amazon.com - BNN Bloomberg
FierceBiotech Feb 18, 2026 Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
FierceBiotech Feb 18, 2026 Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug
FierceBiotech Feb 18, 2026 Gut-focused Rasayana ingests gastrointestinal candidate in $36M licensing deal
Thermo Fisher Feb 18, 2026 Thermo Fisher Launches Kit for Sequential Protein, DNA and RNA Extraction - Contract Pharma
Endpoints News Feb 18, 2026 Novartis signs macrocyclic deal with Unnatural Products for $100M upfront